Arbutus’ LNP Licensee Alnylam Announces FDA Approval of ONPATTRO (patisiran), for the Treatment of ATTR Amyloidosis Biotech Investing
Nightstar Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights Genetics Investing
Adherium Launches Hailie Solution Direct-to-Consumer in the U.S. for Better Asthma and COPD Management Medical Device Investing
1st Patient Treated for Osteoarthritis Knee Pain in Sorrento Resiniferatoxin Phase 1B Trial Meets Both Safety and Efficacy Expectations Pharmaceutical Investing
New Drug Application Submitted in Japan for INTUNIV (guanfacine hydrochloride extended release) in Adults with ADHD Biotech Investing
Isodiol International Inc. Launches Automated Retail Strategy; Plans National Network of CBD Kiosks Biotech Investing
ASLAN Pharmaceuticals Completes Recruitment for Global Phase 2 Study for Varlitinib in First Line Gastric Cancer Pharmaceutical Investing
Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD Pharmaceutical Investing
Iterum Initiates SURE 1, a Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections Pharmaceutical Investing
Organovo Reports Fiscal First-Quarter 2019 Results; Company Outlines and Expands Key Clinical Development Goals Biotech Investing
